| Year |
Citation |
Score |
| 2022 |
Szulzewsky F, Arora S, Arakaki AKS, Sievers P, Almiron Bonnin DA, Paddison PJ, Sahm F, Cimino PJ, Gujral TS, Holland EC. Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in mice. Genes & Development. PMID 36008139 DOI: 10.1101/gad.349876.122 |
0.325 |
|
| 2021 |
Kanvinde PP, Malla AP, Connolly NP, Szulzewsky F, Anastasiadis P, Ames HM, Kim AJ, Winkles JA, Holland EC, Woodworth GF. Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas. Glia. PMID 33638562 DOI: 10.1002/glia.23984 |
0.303 |
|
| 2020 |
Takadera M, Satomi K, Szulzewsky F, Cimino PJ, Holland EC, Yamamoto T, Ichimura K, Ozawa T. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes. Acta Neuropathologica Communications. 8: 203. PMID 33228790 DOI: 10.1186/s40478-020-01080-8 |
0.306 |
|
| 2020 |
Bohm AK, DePetro JA, Binding CE, Gerber A, Chahley N, Berger ND, Ware MA, Thomas KA, Senapathi U, Bukhari S, Chen C, Chahley E, Grisdale CJ, Lawn S, Yu Y, ... ... Holland EC, et al. In Vitro Modeling of GBM Initiation using PDGF-AA and P53-Null Neural Progenitors. Neuro-Oncology. PMID 32296841 DOI: 10.1093/Neuonc/Noaa093 |
0.317 |
|
| 2020 |
Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, Zhang L, Holland E, Yao L, Qin L, Binder ZA, O'Rourke DM, Brem S, Koumenis C, Gong Y, et al. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Science Translational Medicine. 12. PMID 32102932 DOI: 10.1126/Scitranslmed.Aay7522 |
0.368 |
|
| 2019 |
Pajtler KW, Wei Y, Okonechnikov K, Silva PBG, Vouri M, Zhang L, Brabetz S, Sieber L, Gulley M, Mauermann M, Wedig T, Mack N, Imamura Kawasawa Y, Sharma T, Zuckermann M, ... ... Holland E, et al. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis. Nature Communications. 10: 3914. PMID 31477715 DOI: 10.1038/S41467-019-11884-5 |
0.334 |
|
| 2019 |
Szulzewsky F, Hoellerbauer P, Wu H, Cimino PJ, Michor F, Paddison P, Vasioukhin V, Holland E. GENE-04. THE ONCOGENIC FUNCTIONS OF YAP1-GENE FUSIONS CAN BE INHIBITED BY DISRUPTION OF YAP1-TEAD INTERACTION Neuro-Oncology. 21: vi98-vi98. DOI: 10.1093/Neuonc/Noz175.406 |
0.406 |
|
| 2019 |
Horne E, Xu C, Vicente J, Cimino PJ, Wagenbach M, Hamel E, Gussio R, Diaz P, Uhlenbruck B, Deckwerth T, Wordeman L, Holland E, Stella N. DDIS-29. BRAIN-PENETRANT MICROTUBULE-TARGETING AGENT, ST-401, KILLS GLIOBLASTOMA THROUGH A NOVEL MECHANISM Neuro-Oncology. 21: vi69-vi69. DOI: 10.1093/Neuonc/Noz175.280 |
0.405 |
|
| 2019 |
Pattwell S, Arora S, Cimino PJ, Szulzewsky F, Hoellerbauer P, Hoffstrom B, Boiani N, Ozawa T, Bolouri H, Correnti C, Silber J, Paddison P, Holland E. TMOD-30. CHARACTERIZATION OF AN ALTERNATIVELY SPLICED NTRK2 VARIANT IN GLIOMAS Neuro-Oncology. 21: vi269-vi269. DOI: 10.1093/Neuonc/Noz175.1129 |
0.393 |
|
| 2018 |
Connolly NP, Shetty AC, Stokum JA, Hoeschele I, Siegel MB, Miller CR, Kim AJ, Ho CY, Davila E, Simard JM, Devine SE, Rossmeisl JH, Holland EC, Winkles JA, Woodworth GF. Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma. Scientific Reports. 8: 1180. PMID 29352201 DOI: 10.1038/S41598-018-19451-6 |
0.316 |
|
| 2018 |
Szulzewsky F, Arora S, Hambardzumyan D, Holland E. TMIC-53. IDENTIFICATION OF MYELOID CELL-DERIVED TRANSCRIPTS IN GLIOBLASTOMA Neuro-Oncology. 20: vi268-vi268. DOI: 10.1093/Neuonc/Noy148.1112 |
0.306 |
|
| 2017 |
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim JH, Gorge E, Yanowitch R, Cope W, Vartanian E, Xu R, Zhang T, Pisapia D, Xiang J, Huse J, ... Holland E, et al. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. The Journal of Clinical Investigation. PMID 28394259 DOI: 10.1172/Jci86443 |
0.42 |
|
| 2017 |
Connolly NP, Stokum JA, Schneider CS, Ozawa T, Xu S, Galisteo R, Castellani RJ, Kim AJ, Simard JM, Winkles JA, Holland EC, Woodworth GF. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. Plos One. 12: e0174557. PMID 28358926 DOI: 10.1371/Journal.Pone.0174557 |
0.339 |
|
| 2017 |
Connolly NP, Schneider CS, Shetty A, Xu S, Ozawa T, Kim AJ, Winkles JA, Holland E, Woodworth GF. Abstract 808: PDGF-A overexpression and p53 depletion in rat neural precursor cells induces large brain tumors that resemble human glioblastoma Cancer Research. 77: 808-808. DOI: 10.1158/1538-7445.Am2017-808 |
0.353 |
|
| 2017 |
Wang A, Abecassis I, Wang S, Jones D, Cole B, Leary S, Lockwood C, Ene C, Fallah A, Olson J, Ellenbogen R, Holland E, Ojemann J. Primitive Desmoplastic Neuroepithelial Tumor of the Skull Base Journal of Neurological Surgery Part B: Skull Base. 78: S1-S156. DOI: 10.1055/S-0037-1600828 |
0.332 |
|
| 2016 |
Gammoh N, Fraser J, Puente C, Syred HM, Kang H, Ozawa T, Lam D, Acosta JC, Finch AJ, Holland E, Jiang X. Suppression of autophagy impedes glioblastoma development and induces senescence. Autophagy. 0. PMID 27304681 DOI: 10.1080/15548627.2016.1190053 |
0.391 |
|
| 2015 |
Pattwell S, Ozawa T, Juric-Sekhar G, Holland E. PTPS-23A NOVEL ROLE FOR NEUROTROPHIN SIGNALING IN PEDIATRIC ATYPICAL TERATOID RHABDOID TUMORS Neuro-Oncology. 17: v184.2-v184. DOI: 10.1093/Neuonc/Nov228.23 |
0.415 |
|
| 2014 |
Lindberg N, Jiang Y, Xie Y, Bolouri H, Kastemar M, Olofsson T, Holland EC, Uhrbom L. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14644-51. PMID 25355217 DOI: 10.1523/JNEUROSCI.2977-14.2014 |
0.331 |
|
| 2014 |
Kim Y, Lindberg N, Bolouri H, Delrow J, Ozawa T, Holland E. Abstract LB-27: Develop mutant isocitrate dehydrogenase 1 (IDH1)-expressing gliomas using RCAS/tv-a technology Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-27 |
0.4 |
|
| 2014 |
Ozawa T, Ellison D, Gilbertson R, Holland E. PM-15C11orf95-RELA FUSION ALONE IS SUFFICIENT TO FORM HUMAN SUPRATENTORIAL EPENDYMOMA-LIKE TUMOR IN MICE Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou268.15 |
0.444 |
|
| 2013 |
Agus DB, Alexander JF, Arap W, Ashili S, Aslan JE, Austin RH, Backman V, Bethel KJ, Bonneau R, Chen WC, Chen-Tanyolac C, Choi NC, Curley SA, Dallas M, ... ... Holland EC, et al. A physical sciences network characterization of non-tumorigenic and metastatic cells. Scientific Reports. 3: 1449. PMID 23618955 DOI: 10.1038/Srep01449 |
0.431 |
|
| 2013 |
Huse JT, Holland E, DeAngelis LM. Glioblastoma: molecular analysis and clinical implications. Annual Review of Medicine. 64: 59-70. PMID 23043492 DOI: 10.1146/Annurev-Med-100711-143028 |
0.35 |
|
| 2012 |
Dougherty JD, Fomchenko EI, Akuffo AA, Schmidt E, Helmy KY, Bazzoli E, Brennan CW, Holland EC, Milosevic A. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Research. 72: 4856-68. PMID 22865458 DOI: 10.1158/0008-5472.Can-11-2632 |
0.329 |
|
| 2012 |
Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 60: 502-14. PMID 22379614 DOI: 10.1002/Glia.21264 |
0.301 |
|
| 2012 |
Li Y, Ferris A, Lewis BC, Orsulic S, Williams BO, Holland EC, Hughes SH. The RCAS/TVA somatic gene transfer method in modeling human cancer Genetically Engineered Mice For Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. 83-111. DOI: 10.1007/978-0-387-69805-2_5 |
0.652 |
|
| 2011 |
Hambardzumyan D, Cheng YK, Haeno H, Holland EC, Michor F. The probable cell of origin of NF1- and PDGF-driven glioblastomas. Plos One. 6: e24454. PMID 21931722 DOI: 10.1371/Journal.Pone.0024454 |
0.315 |
|
| 2011 |
Fomchenko EI, Dougherty JD, Helmy KY, Katz AM, Pietras A, Brennan C, Huse JT, Milosevic A, Holland EC. Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression. Plos One. 6: e20605. PMID 21754979 DOI: 10.1371/Journal.Pone.0020605 |
0.313 |
|
| 2011 |
Hambardzumyan D, Parada LF, Holland EC, Charest A. Genetic modeling of gliomas in mice: new tools to tackle old problems. Glia. 59: 1155-68. PMID 21305617 DOI: 10.1002/glia.21142 |
0.321 |
|
| 2011 |
Jones TS, Holland EC. Molecular pathogenesis of malignant glial tumors. Toxicologic Pathology. 39: 158-66. PMID 21078918 DOI: 10.1177/0192623310387617 |
0.301 |
|
| 2010 |
Charles N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D, Holland EC. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 6: 141-52. PMID 20144787 DOI: 10.1016/j.stem.2010.01.001 |
0.322 |
|
| 2010 |
See WL, Miller JP, Squatrito M, Holland E, Resh MD, Koff A. Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene. 29: 1720-31. PMID 20062078 DOI: 10.1038/Onc.2009.465 |
0.345 |
|
| 2009 |
Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. Plos One. 4: e7752. PMID 19915670 DOI: 10.1371/Journal.Pone.0007752 |
0.333 |
|
| 2009 |
Momota H, Holland EC. Mouse models of CNS embryonal tumors Brain Tumor Pathology. 26: 43-50. PMID 19856214 DOI: 10.1007/s10014-009-0253-0 |
0.314 |
|
| 2009 |
Bleau AM, Huse JT, Holland EC. The ABCG2 resistance network of glioblastoma. Cell Cycle (Georgetown, Tex.). 8: 2936-44. PMID 19713741 |
0.301 |
|
| 2008 |
Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Panageas K, Gu B, Rao J, Fleisher M, Holland E, DeAngelis LM, Hormigo A. A longitudinal prospective study of YKL-40 and matrix metalloproteinase-9 (MMP-9) as serum tumor markers in gliomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2038. PMID 27948071 DOI: 10.1200/Jco.2008.26.15_Suppl.2038 |
0.314 |
|
| 2008 |
Hambardzumyan D, Becher OJ, Holland EC. Cancer stem cells and survival pathways Cell Cycle. 7: 1371-1378. PMID 18421251 |
0.305 |
|
| 2008 |
Bleau AM, Howard BM, Taylor LA, Gursel D, Greenfield JP, Lim Tung HY, Holland EC, Boockvar JA. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurgical Focus. 24: E28. PMID 18341405 DOI: 10.3171/FOC/2008/24/3-4/E27 |
0.313 |
|
| 2007 |
Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R, Singh B, Holland E, Koff A. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). The Embo Journal. 26: 4683-93. PMID 17948060 DOI: 10.1038/Sj.Emboj.7601886 |
0.424 |
|
| 2007 |
Tchougounova E, Kastemar M, Bråsäter D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma Oncogene. 26: 6289-6296. PMID 17438529 DOI: 10.1038/sj.onc.1210455 |
0.315 |
|
| 2007 |
Fomchenko EI, Holland EC. Platelet-Derived Growth Factor-Mediated Gliomagenesis and Brain Tumor Recruitment Neurosurgery Clinics of North America. 18: 39-58. PMID 17244553 DOI: 10.1016/j.nec.2006.10.006 |
0.315 |
|
| 2006 |
Fomchenko EI, Holland EC. Mouse models of brain tumors and their applications in preclinical trials Clinical Cancer Research. 12: 5288-5297. PMID 17000661 DOI: 10.1158/1078-0432.CCR-06-0438 |
0.339 |
|
| 2005 |
Momota H, Holland EC. Bioluminescence technology for imaging cell proliferation Current Opinion in Biotechnology. 16: 681-686. PMID 16263256 DOI: 10.1016/j.copbio.2005.10.012 |
0.336 |
|
| 2005 |
Hu X, Holland EC. Applications of mouse glioma models in preclinical trials. Mutation Research. 576: 54-65. PMID 16011838 DOI: 10.1016/j.mrfmmm.2004.08.023 |
0.332 |
|
| 2005 |
Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia (New York, N.Y.). 7: 356-68. PMID 15967113 DOI: 10.1593/Neo.04595 |
0.361 |
|
| 2005 |
Uhrbom L, Kastemar M, Johansson FK, Westermark B, Holland EC. Cell type-specific tumor suppression by Ink4a and Arf in kras-induced mouse gliomagenesis Cancer Research. 65: 2065-2069. PMID 15781613 DOI: 10.1158/0008-5472.CAN-04-3588 |
0.343 |
|
| 2003 |
Hesselager G, Holland EC, Rutka JT, Parsa AT. Using mice to decipher the molecular genetics of brain tumors Neurosurgery. 53: 685-695. PMID 12943584 |
0.324 |
|
| 2002 |
Weiss WA, Israel M, Cobbs C, Holland E, James CD, Louis DN, Marks C, McClatchey AI, Roberts T, Van Dyke T, Wetmore C, Chiu IM, Giovannini M, Guha A, Higgins RJ, et al. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene. 21: 7453-63. PMID 12386807 DOI: 10.1038/Sj.Onc.1205936 |
0.329 |
|
| 2002 |
Uhrbom L, Dai C, Celestino JC, Rosenblum MK, Fuller GN, Holland EC. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Research. 62: 5551-8. PMID 12359767 |
0.314 |
|
| 2002 |
Fults D, Pedone C, Dai C, Holland EC. MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo Neoplasia. 4: 32-39. PMID 11922389 DOI: 10.1038/sj/neo/7900200 |
0.332 |
|
| 2002 |
Begemann M, Fuller GN, Holland EC. Genetic modeling of glioma formation in mice. Brain Pathology (Zurich, Switzerland). 12: 117-32. PMID 11770894 |
0.328 |
|
| 2001 |
Uhrbom L, Holland EC. Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors Journal of Neuro-Oncology. 53: 297-305. PMID 11718262 DOI: 10.1023/A:1012208314436 |
0.362 |
|
| 2001 |
Holland EC. Brain tumor animal models: Importance and progress Current Opinion in Oncology. 13: 143-147. PMID 11307055 DOI: 10.1097/00001622-200105000-00002 |
0.332 |
|
| 2001 |
Rao G, Fults D, Holland E. 725 Somatic Cell Gene Transfer into Model PNET in NTV-a Transgenic Mice Neurosurgery. 49: 513-514. DOI: 10.1097/00006123-200108000-00089 |
0.361 |
|
| 2000 |
Holland EC, Li Y, Celestino J, Dai C, Schaefer L, Sawaya RA, Fuller GN. Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. The American Journal of Pathology. 157: 1031-7. PMID 10980141 DOI: 10.1016/S0002-9440(10)64615-9 |
0.354 |
|
| 2000 |
Holland EC. A mouse model for glioma: Biology, pathology, and therapeutic opportunities Toxicologic Pathology. 28: 171-177. PMID 10669005 |
0.339 |
|
| 1999 |
Fisher GH, Orsulic S, Holland E, Hively WP, Li Y, Lewis BC, Williams BO, Varmus HE. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene. 18: 5253-60. PMID 10498877 DOI: 10.1038/Sj.Onc.1203087 |
0.676 |
|
| 1999 |
Dressman MM, Holland E, Polymeropoulos MH, Lavedan CN. Signing on to expression profiles Nature Genetics. 23: 42-42. DOI: 10.1038/14295 |
0.356 |
|
| 1998 |
Holland EC, Hively WP, DePinho RA, Varmus HE. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes & Development. 12: 3675-85. PMID 9851974 DOI: 10.1101/Gad.12.23.3675 |
0.494 |
|
| 1998 |
Holland EC, Hively WP, Gallo V, Varmus HE. Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. Genes & Development. 12: 3644-9. PMID 9851971 DOI: 10.1101/Gad.12.23.3644 |
0.448 |
|
| 1998 |
Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proceedings of the National Academy of Sciences of the United States of America. 95: 1218-23. PMID 9448312 DOI: 10.1073/Pnas.95.3.1218 |
0.515 |
|
| Show low-probability matches. |